Início
Mercados
Gráficos e ideias
Algo
Notícias
Market
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Heatmap
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
CLNN
#4115
Clene Inc. Common Stock
6.640
0
USD
+2.47%
Setor:
Consumo básico
Base:
USD
Moeda do lucro:
USD
Faixa diária
Faixa anual
Mudança diária
+2.47%
Mudança mensal
+16.49%
Mudança em 6 meses
+48.55%
Mudança anual
+48.55%
Fechamento anterior
6.480
0
Abrir
6.740
0
Bid
Ask
Mínimo
6.570
0
High
6.740
0
Volume
13
Mercados
Ações
Consumo básico
CLNN
Abrir gráfico completo
Financials
Visão geral
Relatórios
Estatísticas
Trimestral
Ano
Valor
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
2.98 M
3.16 M
3.85 M
6.42 M
8.59 M
11.78 M
—
Valuation ratios
Enterprise value
480.98 M
217.84 M
76.7 M
31.33 M
44 M
85.79 M
254.61 M
Price to earnings ratio
-9.73
-9.62
-2.07
-0.62
-0.94
-2.21
-5.54
Price to sales ratio
910.51
129.66
130.97
47.17
107.97
289.36
680.11
Price to cash flow ratio
-9.91
-2.71
-1.59
-1.02
-1.73
-3.12
-8.81
Price to book ratio
550.04
7.44
19.14
2.3
-4.17
-3.29
-7.19
Enterprise value to EBITDA ratio
-25.25
-4.29
-3.5
-0.81
-3.38
-9.76
-22.02
Profitability ratios
Return on assets %
-0.28
-0.15
-0.67
-0.95
-1.44
-1.44
-1.27
Return on equity %
-56.53
-0.77
-9.24
-3.7
4.45
1.49
2.25
Return on invested capital %
-637.21
-1 605.31
-1 167.4
-580.46
-574.78
-696.82
-726.2
Gross margin %
100
100
94.5
81.5
79.53
78.5
345.44
Operating margin %
-9 812.62
-6 912.59
-10.23 K
-6 198.78
-9 676.32
-11.54 K
-74.14 K
EBITDA margin %
-9 173.3
-6 722.68
-3 303.59
-1 686.54
-2 889.47
-3 275
-20.7 K
Net margin %
-9 357.77
-1 347.16
-6 325.16
-7 569.42
-11.52 K
-13.09 K
-98.9 K
Liquidity ratios
Quick ratio
5.38
9.05
2.1
1.53
1.56
0.83
5.28
Current ratio
5.4
9.06
2.11
1.53
1.57
0.83
5.3
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0
0.01
0.01
0.01
0.01
0.01
0.01
Solvency ratios
Debt to assets ratio
0.06
0.15
0.49
0.43
0.39
1.2
4.01
Debt to equity ratio
11.52
0.74
6.78
1.67
-1.19
-1.24
-9.84
Long term debt to total assets ratio
0.03
0.07
0.36
0.32
0.2
0.98
3.18
Long term debt to total equity ratio
5.72
0.37
4.91
1.26
-0.62
-1.01
-7.73
Per share metrics
Operating cash flow per share
-18.19
-30.29
-11.97
-5.75
-3.07
-1.88
-1.94
EBIT per share
-19.42
-43.72
-14.85
-7.73
-4.76
-2.34
-2.39
EBITDA per share
-18.16
-42.52
-4.79
-2.1
-1.42
-0.66
-0.69
Total debt per share
3.77
8.15
6.73
4.27
1.52
2.22
9.03
Cash per share
56.95
44.04
7.15
6.67
1.75
0.53
3.17
Net current asset value per share
60.52
47.75
8.95
7.4
2.32
0.91
5.06
Tangible book value per share
0.33
11.02
0.99
2.55
-1.27
-1.78
-4.45
Working capital per share
49.31
42.48
4.7
2.58
0.84
-0.18
1.15
Book value per share
0.33
11.02
0.99
2.55
-1.27
-1.78
-4.45
Notícias
Acionista com 10% da Clene Inc. vende US$ 119.889 em ações
Acionista com mais de 10% da Clene Inc. vende ações no valor de US$ 161 mil
Clene Inc. ten percent owner sells $161k in shares
Clene Inc. ten percent owner sells $256k in shares
FDA concede à Clene reunião presencial para discutir dados de biomarcadores de medicamento para ELA
FDA grants Clene in-person meeting to discuss ALS drug biomarker data
Clene garante US$ 28 milhões em oferta direta registrada para medicamento contra ELA
Clene secures $28 million in registered direct offering for ALS drug
Clene Inc. ten percent owner Ugwumba sells $78k in shares
Ugwumba Chidozie vende ações da Clene Inc. (CLNN) no valor de US$ 73.123
Ugwumba Chidozie sells Clene Inc. (CLNN) stock worth $73,123
Ugwumba vende US$ 73 mil em ações da Clene Inc